Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment

See what CB Insights has to offer


Seed VC | Alive

Total Raised


Last Raised

$3.1M | 11 yrs ago

About Corhythm

Corhythm is developing an implantable treatment that detects early onset of atrial fibrillation and chronic heart failure. The device uses recent advances in semiconductor technology and materials science to provide pacing and defibrillation, and delivers targeted medications when an atrial fibrillation is detected.

Corhythm Headquarter Location

12500 Network Blvd. Suite 112

San Antonio, Texas, 78249,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.